Pages that link to "Q72771515"
Jump to navigation
Jump to search
The following pages link to Molecular and clinical aspects of the Neu/ErbB-2 receptor tyrosine kinase (Q72771515):
Displaying 13 items.
- A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor (Q24648517) (← links)
- Hormone refractory prostate cancer (Q33800958) (← links)
- Bivalence of EGF-like ligands drives the ErbB signaling network (Q33887274) (← links)
- Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers (Q33888963) (← links)
- ErbB receptors and EGF-like ligands: cell lineage determination and oncogenesis through combinatorial signaling (Q33959306) (← links)
- Antisense therapeutics: from theory to clinical practice (Q35153742) (← links)
- Enhanced gene delivery to HER-2-overexpressing breast cancer cells by modified immunolipoplexes conjugated with the anti-HER-2 antibody (Q40652580) (← links)
- Inhibitory effects of the combination of HER-2 antisense oligonucleotide and chemotherapeutic agents used for the treatment of human breast cancer (Q40771348) (← links)
- The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions (Q41554100) (← links)
- The ErbB-2/HER2 oncogenic receptor of adenocarcinomas: from orphanhood to multiple stromal ligands (Q41738022) (← links)
- Ribozyme targeting of HER-2 inhibits pancreatic cancer cell growth in vivo (Q43723222) (← links)
- Autocrine regulation of human urothelial cell proliferation and migration during regenerative responses in vitro (Q46476362) (← links)
- Overexpression of activated neu/erbB2 initiates immortalization and malignant transformation of immature Schwann cells in vitro. (Q52172506) (← links)